CLINICAL_TRIALS
trial_result
· 2020-12-03
Clinical Trial Update: Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF [Phase 2]
Summary
Phase 2 trial evaluating patient-reported outcomes in vericiguat-treated patients with heart failure with preserved ejection fraction (HFpEF).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Chronic Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: COMPLETED | Results posted: 2020-12-03